Surveillance for adverse events following immunization (AEFI) in Switzerland-1991-2001

被引:23
作者
Schumacher, Z. [1 ]
Bourquin, C. [2 ]
Heininger, U. [1 ]
机构
[1] Univ Childrens Hosp UKBB, Div Infect Dis & Vaccines, CH-4005 Basel, Switzerland
[2] Bundesamt Gesundheit Swiss Fed Off Publ Hlth, CH-3007 Bern, Switzerland
关键词
AEFI (adverse events following immunization); Surveillance; Passive; SUDDEN UNEXPECTED DEATH; HEPATITIS-B VACCINATION; REPORTING SYSTEM; RISK; SAFETY; VAERS; AGE;
D O I
10.1016/j.vaccine.2010.04.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In Switzerland, reporting of adverse events following immunization (AEFI) has been mandatory by law since 1988. The goal of this study was a detailed analysis of reported AEFI received by the Swiss Federal Office of Public Health between 1991 and 2001. Overall, 1013 AEFI were reported which translates to 2.7 reports per 100,000 vaccine doses distributed during the study period. Most AEFI were classified as general systemic reactions (47%), followed by local (26%), neurological (16%) and allergic reactions (13%). The majority of all reported AEFI (N=513: 51%) had occurred in individuals 16 years and older. Causal relationship between immunization and AEFI was probable in 91 (10%) of 909 assessable reports and very likely or certain in 194(21%), the majority of which (88%) were local reactions. Vaccines distributed in Switzerland have proven to be generally safe. Limitations of the passive surveillance system, however, warrant improvements in the future. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4059 / 4064
页数:6
相关论文
共 22 条
  • [1] Hepatitis B vaccination and the risk of multiple sclerosis
    Ascherio, A
    Zhang, SM
    Hernán, MA
    Olek, MJ
    Coplan, PM
    Brodovicz, K
    Walker, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) : 327 - 332
  • [2] The Brighton collaboration - enhancing vaccine safety
    Bonhoeffer, J
    Kohl, K
    Chen, R
    Duclos, P
    Heijbel, H
    Heininger, U
    Jefferson, T
    Loupi, E
    [J]. VACCINE, 2004, 22 (15-16) : 2046 - 2046
  • [3] Adverse events following immunization: perception and evidence
    Bonhoeffer, Jan
    Heininger, Ulrich
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2007, 20 (03) : 237 - 246
  • [4] Descriptive epidemiology of adverse events after immunization: Reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994
    Braun, MM
    Ellenberg, SS
    [J]. JOURNAL OF PEDIATRICS, 1997, 131 (04) : 529 - 535
  • [5] *BUND GES, 1993, BAG B, V13, P236
  • [6] FISHER LD, 1993, WILEY SERIES PROBABI
  • [7] The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study
    Fleming, PJ
    Blair, PS
    Ward, M
    Tripp, J
    Smith, IJ
    Golding, J
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7290): : 822 - 825
  • [8] Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life:: Safety, immunogenicity and persistence of antibody responses
    Heininger, U.
    Saenger, R.
    Jacquet, J. M.
    Schuerman, L.
    [J]. VACCINE, 2007, 25 (06) : 1055 - 1063
  • [9] Recombinant hepatitis B vaccine and the risk of multiple sclerosis -: A prospective study
    Hernán, MA
    Jick, SS
    Olek, MJ
    Jick, H
    [J]. NEUROLOGY, 2004, 63 (05) : 838 - 842
  • [10] Sudden unexpected death vaccination in infants under 3 months of age and vaccination status -: a case-control study
    Jonville-Béra, AP
    Autret-Leca, E
    Barbeillon, F
    Paris-Llado, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) : 271 - 276